Lazydays (GORV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GORV Lazydays

Watchlist

1.020
+0.070+7.38%

Close Nov 22 16:00 ET

1.030
+0.010+0.97%

Post 18:47 ET

61.14MMarket Cap-71P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
BenzingaNov 20 16:10 ET
Lazydays Holdings' Inaction on Stock Buybacks Raises Investor Concerns
TipRanksNov 20 01:00 ET
Lazydays Holdings, Inc. (GORV) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 19 15:12 ET · Conference Call
Lazydays Holdings, Inc. (GORV) Q3 2024 Earnings Call Transcript
Earnings Call TranscriptsNov 19 15:07 ET
8-K: LAZYDAYS REPORTS THIRD QUARTER 2024 RESULTS
SECNov 19 11:44 ET
Express News | Lazyday Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results
BenzingaNov 19 10:51 ET

Comments

Jaguar8

Nov 19 19:27

One of my watchlist tomorrow. Why? 13G 77% stake (increased from 46%)

$Lazydays (GORV.US)$

Stock_Drift

Nov 19 17:28

After Hours Ticks. 6:26pm

$Fresh2 (FRES.US)$ $Opus Genetics (IRD.US)$ $Sangamo Therapeutics (SGMO.US)$ $Kindly MD (KDLY.US)$ $Edesa Biotech (EDSA.US)$ $Sadot (SDOT.US)$ $Lazydays (GORV.US)$ $Zeo Energy (ZEO.US)$ $Hall Of Fame Resort & Entertainment (HOFV.US)$ $Nauticus Robotics (KITT.US)$ $KORE Group (KORE.US)$ $Digital Brands Group (DBGI.US)$ $Hoth Therapeutics (HOTH.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

Trytosaveabit

Nov 19 16:55

Allow me to put a bit of a finer point on it! Hehehe

$Lazydays (GORV.US)$

Trytosaveabit

Nov 19 16:44

Hmm!

$Lazydays (GORV.US)$ SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Coliseum Capital Management, LLC(77.6%),Adam Gray(77.6%), etc.
SEC· 7 mins ago

Father

Nov 15 10:17

$Lazydays (GORV.US)$ whats the deal?

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

GORV Lazydays

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target